Cas:1354000-03-5 2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate manufacturer & supplier

Chemical Name:2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate

CAS.NO:1354000-03-5

Synonyms:MFCD21097794;1-Piperidinecarboxylic acid, 3-bromo-, 1,1-dimethylethyl ester, (3R)-;2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate

Molecular Formula:C₁₀H₁₈BrNO₂

Molecular Weight:264.159

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:296.6±33.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.507

PSA:

Exact Mass:263.052094

LogP:2.21

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD21097794 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD21097794 Use and application,2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate technical grade,usp/ep/jp grade.

Related News: It is delivered to hospitals and pharmacies until it reaches the patient. 2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate manufacturer The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. 2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate vendor It is delivered to hospitals and pharmacies until it reaches the patient. 2-Methyl-2-propanyl (3R)-3-bromo-1-piperidinecarboxylate factory Other possible health risks of PFAS include kidney cancer, testicular cancer and high blood pressure, the researchers added.